Top

Published in:

01-08-2021 | Original Paper

RIPK3 modulates growth factor receptor expression in endothelial cells to support angiogenesis

Authors: Siqi Gao, Courtney T. Griffin

Published in: Angiogenesis | Issue 3/2021

Abstract

Receptor-interacting protein kinase 3 (RIPK3) is a multifunctional intracellular protein that was first recognized as an important component of the necroptosis programmed cell death pathway. RIPK3 is also highly expressed in non-necroptotic murine embryonic endothelial cells (ECs) during vascular development, indicating its potential contribution to angiogenesis. To test this hypothesis, we generated mice lacking endothelial RIPK3 and found non-lethal embryonic and perinatal angiogenesis defects in multiple vascular beds. Our in vitro data indicate that RIPK3 supports angiogenesis by regulating growth factor receptor degradation in ECs. We found that RIPK3 interacted with the membrane trafficking protein myoferlin to sustain expression of vascular endothelial growth factor receptor 2 (VEGFR2) in cultured ECs following vascular endothelial growth factor A (VEGFA) stimulation. Restoration of myoferlin, which was diminished after RIPK3 knockdown, rescued decreased VEGFR2 expression and vascular sprouting in RIPK3-deficient ECs after VEGFA treatment. In addition, we found that RIPK3 modulated expression of genes involved in endothelial identity by inhibiting ERK signaling independently of growth factor receptor turnover. Altogether, our data reveal unexpected non-necroptotic roles for RIPK3 in ECs and evidence that RIPK3 promotes developmental angiogenesis in vivo.

Available only for authorised users

Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK (2009) Phosphorylation-driven assembly of the RIP1–RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137(6):1112–1123. https://doi.org/10.1016/j.cell.2009.05.037CrossRefPubMedPubMedCentral

He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137(6):1100–1111. https://doi.org/10.1016/j.cell.2009.05.021CrossRefPubMed

Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11(10):700–714. https://doi.org/10.1038/nrm2970CrossRefPubMed

Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, Han J (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325(5938):332–336. https://doi.org/10.1126/science.1172308CrossRefPubMed

Samson AL, Zhang Y, Geoghegan ND, Gavin XJ, Davies KA, Mlodzianoski MJ, Whitehead LW, Frank D, Garnish SE, Fitzgibbon C, Hempel A, Young SN, Jacobsen AV, Cawthorne W, Petrie EJ, Faux MC, Shield-Artin K, Lalaoui N, Hildebrand JM, Silke J, Rogers KL, Lessene G, Hawkins ED, Murphy JM (2020) MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis. Nat Commun 11(1):3151. https://doi.org/10.1038/s41467-020-16887-1CrossRefPubMedPubMedCentral

Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA, Marquis RW, Bertin J, Gough PJ, Savvides S, Martinou JC, Bertrand MJ, Vandenabeele P (2014) MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 7(4):971–981. https://doi.org/10.1016/j.celrep.2014.04.026CrossRefPubMed

Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148(1–2):213–227. https://doi.org/10.1016/j.cell.2011.11.031CrossRefPubMed

Yang Z, Wang Y, Zhang Y, He X, Zhong CQ, Ni H, Chen X, Liang Y, Wu J, Zhao S, Zhou D, Han J (2018) RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis. Nat Cell Biol 20(2):186–197. https://doi.org/10.1038/s41556-017-0022-yCrossRefPubMed

Newton K (2015) RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol 25(6):347–353. https://doi.org/10.1016/j.tcb.2015.01.001CrossRefPubMed

10.

Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D’Cruz AA, Hall C, Kaur Spall S, Anderton H, Masters SL, Rashidi M, Wicks IP, Alexander WS, Mitsuuchi Y, Benetatos CA, Condon SM, Wong WW, Silke J, Vaux DL, Vince JE (2015) RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat Commun 6:6282. https://doi.org/10.1038/ncomms7282CrossRefPubMed

11.

Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P, Wallach D (1998) Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9(2):267–276. https://doi.org/10.1016/s1074-7613(00)80609-3CrossRefPubMed

12.

Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW (2000) Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12(6):633–642. https://doi.org/10.1016/s1074-7613(00)80214-9CrossRefPubMed

13.

Yeh WC, de la Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, Mak TW (1998) FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279(5358):1954–1958. https://doi.org/10.1126/science.279.5358.1954CrossRefPubMed

14.

Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, Mocarski ES (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471(7338):368–372. https://doi.org/10.1038/nature09857CrossRefPubMedPubMedCentral

15.

Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, Ben-Moshe T, Mak TW, Wallach D, Green DR (2012) Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 1(5):401–407. https://doi.org/10.1016/j.celrep.2012.03.010CrossRefPubMedPubMedCentral

16.

Dillon CP, Tummers B, Baran K, Green DR (2016) Developmental checkpoints guarded by regulated necrosis. Cell Mol Life Sci 73(11–12):2125–2136. https://doi.org/10.1007/s00018-016-2188-zCrossRefPubMed

17.

Colijn S, Gao S, Ingram KG, Menendez M, Muthukumar V, Silasi-Mansat R, Chmielewska JJ, Hinsdale M, Lupu F, Griffin CT (2020) The NuRD chromatin-remodeling complex enzyme CHD4 prevents hypoxia-induced endothelial Ripk3 transcription and murine embryonic vascular rupture. Cell Death Differ 27(2):618–631. https://doi.org/10.1038/s41418-019-0376-8CrossRefPubMed

18.

Tisch N, Freire-Valls A, Yerbes R, Paredes I, La Porta S, Wang X, Martin-Perez R, Castro L, Wong WW, Coultas L, Strilic B, Grone HJ, Hielscher T, Mogler C, Adams RH, Heiduschka P, Claesson-Welsh L, Mazzone M, Lopez-Rivas A, Schmidt T, Augustin HG, Ruiz de Almodovar C (2019) Caspase-8 modulates physiological and pathological angiogenesis during retina development. J Clin Invest 129(12):5092–5107. https://doi.org/10.1172/JCI122767CrossRefPubMedPubMedCentral

19.

Strilic B, Yang L, Albarran-Juarez J, Wachsmuth L, Han K, Muller UC, Pasparakis M, Offermanns S (2016) Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature 536(7615):215–218. https://doi.org/10.1038/nature19076CrossRefPubMed

20.

Hanggi K, Vasilikos L, Valls AF, Yerbes R, Knop J, Spilgies LM, Rieck K, Misra T, Bertin J, Gough PJ, Schmidt T, de Almodovar CR, Wong WW (2017) RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function. Cell Death Dis 8(2):e2588. https://doi.org/10.1038/cddis.2017.20CrossRefPubMedPubMedCentral

21.

Reventun P, Sanchez-Esteban S, Cook A, Cuadrado I, Roza C, Moreno-Gomez-Toledano R, Munoz C, Zaragoza C, Bosch RJ, Saura M (2020) Bisphenol A induces coronary endothelial cell necroptosis by activating RIP3/CamKII dependent pathway. Sci Rep 10(1):4190. https://doi.org/10.1038/s41598-020-61014-1CrossRefPubMedPubMedCentral

22.

Yang L, Joseph S, Sun T, Hoffmann J, Thevissen S, Offermanns S, Strilic B (2019) TAK1 regulates endothelial cell necroptosis and tumor metastasis. Cell Death Differ 26(10):1987–1997. https://doi.org/10.1038/s41418-018-0271-8CrossRefPubMedPubMedCentral

23.

Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, Komuves L, Ferrando RE, French DM, Webster J, Roose-Girma M, Warming S, Dixit VM (2014) Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343(6177):1357–1360. https://doi.org/10.1126/science.1249361CrossRefPubMed

24.

Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M (2001) Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230(2):230–242. https://doi.org/10.1006/dbio.2000.0106CrossRefPubMed

25.

Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, Barberis A, Benjamin LE, Makinen T, Nobes CD, Adams RH (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483–486. https://doi.org/10.1038/nature09002CrossRefPubMed

26.

Simons M, Gordon E, Claesson-Welsh L (2016) Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol 17(10):611–625. https://doi.org/10.1038/nrm.2016.87CrossRefPubMed

27.

Redpath GM, Sophocleous RA, Turnbull L, Whitchurch CB, Cooper ST (2016) Ferlins show tissue-specific expression and segregate as plasma membrane/late endosomal or trans-Golgi/recycling ferlins. Traffic 17(3):245–266. https://doi.org/10.1111/tra.12370CrossRefPubMed

28.

Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, Erdjument-Bromage H, Shah V, Gratton JP, McNally EM, Tempst P, Sessa WC (2007) Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. J Biol Chem 282(42):30745–30753. https://doi.org/10.1074/jbc.M704798200CrossRefPubMed

29.

Bernatchez PN, Sharma A, Kodaman P, Sessa WC (2009) Myoferlin is critical for endocytosis in endothelial cells. Am J Physiol Cell Physiol 297(3):C484–C492. https://doi.org/10.1152/ajpcell.00498.2008CrossRefPubMedPubMedCentral

30.

Sharma A, Yu C, Leung C, Trane A, Lau M, Utokaparch S, Shaheen F, Sheibani N, Bernatchez P (2010) A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis. Arterioscler Thromb Vasc Biol 30(11):2196–2204. https://doi.org/10.1161/ATVBAHA.110.208108CrossRefPubMedPubMedCentral

31.

Yu C, Sharma A, Trane A, Utokaparch S, Leung C, Bernatchez P (2011) Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo. Vascul Pharmacol 55(1–3):26–33. https://doi.org/10.1016/j.vph.2011.04.001CrossRefPubMed

32.

Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2(7):a006502. https://doi.org/10.1101/cshperspect.a006502CrossRefPubMedPubMedCentral

33.

Simons M (2012) An inside view: VEGF receptor trafficking and signaling. Physiology (Bethesda) 27(4):213–222. https://doi.org/10.1152/physiol.00016.2012CrossRef

34.

Kovalenko D, Yang X, Nadeau RJ, Harkins LK, Friesel R (2003) Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J Biol Chem 278(16):14087–14091. https://doi.org/10.1074/jbc.C200606200CrossRefPubMed

35.

Hata A, Chen YG (2016) TGF-beta signaling from receptors to Smads. Cold Spring Harb Perspect Biol 8(9):022061. https://doi.org/10.1101/cshperspect.a022061CrossRef

36.

Deng Y, Larrivee B, Zhuang ZW, Atri D, Moraes F, Prahst C, Eichmann A, Simons M (2013) Endothelial RAF1/ERK activation regulates arterial morphogenesis. Blood 121(19):3988–3996. https://doi.org/10.1182/blood-2012-12-474601CrossRefPubMedPubMedCentral

37.

Deng Y, Atri D, Eichmann A, Simons M (2013) Endothelial ERK signaling controls lymphatic fate specification. J Clin Invest 123(3):1202–1215. https://doi.org/10.1172/JCI63034CrossRefPubMedPubMedCentral

38.

Eichmann A, Simons M (2012) VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol 24(2):188–193. https://doi.org/10.1016/j.ceb.2012.02.002CrossRefPubMedPubMedCentral

39.

Yoon S, Kovalenko A, Bogdanov K, Wallach D (2017) MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation. Immunity 47(1):51-65 e57. https://doi.org/10.1016/j.immuni.2017.06.001CrossRefPubMed

40.

Douanne T, Andre-Gregoire G, Trillet K, Thys A, Papin A, Feyeux M, Hulin P, Chiron D, Gavard J, Bidere N (2019) Pannexin-1 limits the production of proinflammatory cytokines during necroptosis. EMBO Rep 20(10):e47840. doi:https://doi.org/10.15252/embr.201947840CrossRefPubMedPubMedCentral

41.

Rasheed A, Robichaud S, Nguyen MA, Geoffrion M, Wyatt H, Cottee ML, Dennison T, Pietrangelo A, Lee R, Lagace TA, Ouimet M, Rayner KJ (2020) Loss of MLKL (mixed lineage kinase domain-like protein) decreases necrotic core but increases macrophage lipid accumulation in atherosclerosis. Arterioscler Thromb Vasc Biol 40(5):1155–1167. https://doi.org/10.1161/ATVBAHA.119.313640CrossRefPubMed

42.

Bruno J, Brumfield A, Chaudhary N, Iaea D, McGraw TE (2016) SEC16A is a RAB10 effector required for insulin-stimulated GLUT4 trafficking in adipocytes. J Cell Biol 214(1):61–76. doi:https://doi.org/10.1083/jcb.201509052CrossRefPubMedPubMedCentral

43.

Colijn S, Muthukumar V, Xie J, Gao S, Griffin CT (2020) Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis. Dis Model Mech 13(1):dmm041962. https://doi.org/10.1242/dmm.041962CrossRefPubMedPubMedCentral

44.

Fantin A, Vieira JM, Plein A, Maden CH, Ruhrberg C (2013) The embryonic mouse hindbrain as a qualitative and quantitative model for studying the molecular and cellular mechanisms of angiogenesis. Nat Protoc 8(2):418–429. https://doi.org/10.1038/nprot.2013.015CrossRefPubMedPubMedCentral

45.

Montoya-Zegarra JA, Russo E, Runge P, Jadhav M, Willrodt AH, Stoma S, Norrelykke SF, Detmar M, Halin C (2019) AutoTube: a novel software for the automated morphometric analysis of vascular networks in tissues. Angiogenesis 22(2):223–236. https://doi.org/10.1007/s10456-018-9652-3CrossRefPubMed

46.

Renier N, Wu Z, Simon DJ, Yang J, Ariel P, Tessier-Lavigne M (2014) iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159(4):896–910. https://doi.org/10.1016/j.cell.2014.10.010CrossRefPubMed

47.

Tual-Chalot S, Allinson KR, Fruttiger M, Arthur HM (2013) Whole mount immunofluorescent staining of the neonatal mouse retina to investigate angiogenesis in vivo. J Vis Exp 77:e50546. https://doi.org/10.3791/50546CrossRef

48.

Nakatsu MN, Davis J, Hughes CC (2007) Optimized fibrin gel bead assay for the study of angiogenesis. J Vis Exp (3):186. https://doi.org/10.3791/186

Title: RIPK3 modulates growth factor receptor expression in endothelial cells to support angiogenesis
Authors: Siqi Gao
Courtney T. Griffin
Publication date: 01-08-2021
Publisher: Springer Netherlands
Published in: Angiogenesis / Issue 3/2021
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI: https://doi.org/10.1007/s10456-020-09763-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

Linalool inhibits the angiogenic activity of endothelial cells by downregulating intracellular ATP levels and activating TRPM8

Correction to: Phosphorylation of pericyte FAK‑Y861 affects tumour cell apoptosis and tumour blood vessel regression

Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance

A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner

Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials